Literature DB >> 17879922

Reinfection in patients with Lyme disease.

Robert B Nadelman1, Gary P Wormser.   

Abstract

Lyme disease is the most common tick-borne infection in the United States and Europe. A surprising number of patients experience a subsequent episode of Lyme disease after the first episode has resolved. Reinfection has been well-documented only after successfully treated early infection (nearly always erythema migrans) and can often be recognized clinically by the development of a repeat episode of erythema migrans occurring at a different location on the skin during months when the principal tick vectors are abundant in the environment. Limited data suggest that the clinical and laboratory manifestations of reinfection in patients with Lyme disease with erythema migrans are not very different from those of initial infection. Patients with recurrent infections afford an opportunity to study the role of the immune response in this illness. Because patients with early Lyme disease continue to remain at high risk for reinfection, this population should be targeted for education about prevention of Lyme disease.

Entities:  

Mesh:

Year:  2007        PMID: 17879922     DOI: 10.1086/521256

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  25 in total

1.  Provider knowledge, attitudes, and practices regarding Lyme disease in Arkansas.

Authors:  Dana Hill; Talmage Holmes
Journal:  J Community Health       Date:  2015-04

2.  Lyme disease.

Authors:  Eugene D Shapiro
Journal:  N Engl J Med       Date:  2014-08-14       Impact factor: 91.245

3.  A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.

Authors:  Nina Wressnigg; P Noel Barrett; Eva-Maria Pöllabauer; Maria O'Rourke; Daniel Portsmouth; Michael G Schwendinger; Brian A Crowe; Ian Livey; Thomas Dvorak; Bernhard Schmitt; Markus Zeitlinger; Herwig Kollaritsch; Meral Esen; Peter G Kremsner; Tomas Jelinek; Roland Aschoff; Roland Weisser; Ingomar F K Naudts; Gerald Aichinger
Journal:  Clin Vaccine Immunol       Date:  2014-09-03

Review 4.  Clinical practice. Lyme disease.

Authors:  Eugene D Shapiro
Journal:  N Engl J Med       Date:  2014-05-01       Impact factor: 91.245

5.  Differentiation of reinfection from relapse in recurrent Lyme disease.

Authors:  Robert B Nadelman; Klára Hanincová; Priyanka Mukherjee; Dionysios Liveris; John Nowakowski; Donna McKenna; Dustin Brisson; Denise Cooper; Susan Bittker; Gul Madison; Diane Holmgren; Ira Schwartz; Gary P Wormser
Journal:  N Engl J Med       Date:  2012-11-15       Impact factor: 91.245

6.  Ocular Lyme borreliosis as a rare presentation of unilateral vision loss.

Authors:  Jeffrey Patterson-Fortin; Anita Kohli; Maria J Suarez; P Elliott Miller
Journal:  BMJ Case Rep       Date:  2016-04-25

7.  Laboratory diagnostics for Lyme disease.

Authors:  L R Lindsay; K Bernat; A Dibernardo
Journal:  Can Commun Dis Rep       Date:  2014-05-29

Review 8.  Laboratory Diagnosis of Lyme Borreliosis.

Authors:  John A Branda; Allen C Steere
Journal:  Clin Microbiol Rev       Date:  2021-01-27       Impact factor: 26.132

9.  Lyme Disease in Humans.

Authors:  Justin D Radolf; Klemen Strle; Jacob E Lemieux; Franc Strle
Journal:  Curr Issues Mol Biol       Date:  2020-12-11       Impact factor: 2.081

10.  Lyme disease: clinical diagnosis and treatment.

Authors:  T F Hatchette; I Davis; B L Johnston
Journal:  Can Commun Dis Rep       Date:  2014-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.